Oy Faron Pharmaceuticals LTD. Company Profile

04:09 EDT 18th March 2018 | BioPortfolio

Faron Pharmaceuticals Ltd. ("Faron") is a drug discovery and drug development service company. It was founded by a group of R&D professionals, and joined by business and legal advisors with excellent track records.Faron has very good connections to research groups at non-commercial environments, e.g. at universities, in which the majority of new biomedical innovations are made nowadays. Faron's strategy is to become a significant value adding -partner for research group -based projects as well as for all commercial partners utilizing this innovation channel. Faron also develops its own projects, and some proprietary IP-rights have been transferred to the Company at its inception. Current projects focus on cancer, inflammation and trauma.


Itäinen Pitkäkatu 4 B,


Phone: 358 2 478 8400
Fax: 358 2 478 8411

News Articles [526 Associated News Articles listed on BioPortfolio]

BRIEF—Faron Pharmaceuticals inks deal with CRO ahead of pivotal readout

London-listed Faron Pharmaceuticals has agreed terms for German CRO Lyocontract to manufacture Traumakine,…

Faron Pharmaceuticals Oy: FDA grants Fast Track Designation to Faron for Traumakine®

Faron Pharmaceuticals Ltd("Faron" or the "Company") FDA grants Fast Track Designation to Faron for Traumakine® Faron's wholly-owned product for Acute Respiratory Distress Syndrome o...

A 'thrilling' year ahead for Faron Pharmaceuticals with Phase III Traumakine results in Q2

Markku Jalkanen, chief executive at Faron Pharmaceuticals Oy (LON:FARN), caught up with Proactive following their £15mln funding aimed at accelerating the development of its two lead products. Ja...

Faron's IND for acute respiratory distress syndrome drug gets FDA nod

The FDA approved Faron Pharmaceuticals' investigational new drug application for Traumakine, which is being developed as a tr -More- 

Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug

Update (10/10/2017): Faron Pharmaceuticals’ fundraising has been oversubscribed, which reflects the excitement around its drug candidate, Traumakine. By securing £10M, Faron matches its IPO ...

Faron Pharma chief hopes for global patent protection for Clevegen

Markku Jalkanen, chief executive of Faron Pharmaceuticals Ltd (LON:FARN), says he expects Clevegen, a drug that uses the body’s own immune system to kill cancer, to be granted patent protecti...

Faron establishes second Traumakine manufacturing site as it prepares for commercialisation

The read-out from the recently-completed INTEREST study is due later this half and Faron is getting its house in order should the data come back positive

Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer

Faron Pharmaceuticals Oy("Faron" or the "Company") Appointment of Chief Commercial Officer Dr. Juhana Heinonen, previously AstraZeneca's Global Marketing Director, to steer commercia...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]


PubMed Articles [118 Associated PubMed Articles listed on BioPortfolio]

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [210 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1303 Associated Companies listed on BioPortfolio]

Oy Faron Pharmaceuticals LTD.

Faron Pharmaceuticals Ltd. ("Faron") is a drug discovery and drug development service company. It was founded by a group of R&D professionals, and joined by business and legal advisors with excellent ...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

Avanir Pharmaceuticals

AVANIR Pharmaceuticals, formerly LIDAK Pharmaceuticals, is a development stage company organized to discover, develop, and market novel therapeutic products to treat human diseases.

More Information about "Oy Faron Pharmaceuticals LTD." on BioPortfolio

We have published hundreds of Oy Faron Pharmaceuticals LTD. news stories on BioPortfolio along with dozens of Oy Faron Pharmaceuticals LTD. Clinical Trials and PubMed Articles about Oy Faron Pharmaceuticals LTD. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oy Faron Pharmaceuticals LTD. Companies in our database. You can also find out about relevant Oy Faron Pharmaceuticals LTD. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Corporate Database Quicklinks

Searches Linking to this Company Record